Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTreatment OutcomeImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseTime FactorsBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidStem Cell TransplantationImmunosuppressionLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinAcute DiseaseHeart TransplantationSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesSurvival AnalysisHLA AntigensMyelodysplastic SyndromesRetrospective StudiesLung TransplantationCyclosporineActuarial AnalysisHematologic DiseasesBone DensityLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectFollow-Up StudiesCell DifferentiationGraft vs Leukemia EffectCytarabineSurvival RateLeukocyte CountCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CDisease-Free SurvivalEtoposideFlow CytometryLymphomaMultiple MyelomaCells, CulturedFatal OutcomeAntigens, CD34Hodgkin DiseaseMice, KnockoutPrognosisInfectionCell TransplantationCord Blood Stem Cell TransplantationGranulocytes